| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/25/2005 | US20050187639 Soft tissue implants and anti-scarring agents |
| 08/25/2005 | US20050187611 Drug coating with topcoat |
| 08/25/2005 | US20050187600 Electrical devices and anti-scarring agents |
| 08/25/2005 | US20050187301 granulates containing 2-[4-[(Z)-4-chloro-1,2-di(phenyl)but-1-enyl]phenoxy]ethanol, isomers, stereoisomers, salts or metabolites, in combination with excipients, having inproved solubility; dosage form of existing drug; selective estrogen receptor modulators |
| 08/25/2005 | US20050187249 Lypohilization product |
| 08/25/2005 | US20050187245 Stable amorphous forms of montelukast sodium |
| 08/25/2005 | US20050187212 Pharmaceutical composition for topical delivery of meloxicam |
| 08/25/2005 | US20050187200 Methods and reagents for the treatment of inflammatory disorders |
| 08/25/2005 | US20050187186 useful for the treatment of cancer and other hyperproliferative disorders; a sphingolipid; lactic acid; and optionally a stabilizing agent; emulsion |
| 08/25/2005 | US20050187158 comprises erythropoietin (EPO) and a pharmaceutically acceptable diluent, adjuvant, or carrier; to be applied locally and superficially; wound healing agents; alopecia; disease or disorder of the skin or the eye |
| 08/25/2005 | US20050187143 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 04% by weight of zinc based on the insulin content of the formulation. |
| 08/25/2005 | US20050187142 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.4% by weight of zinc based on the insulin content of the formulation. |
| 08/25/2005 | US20050187140 Implanting a spinal implant by infiltrating a tissue of a host near the implant with an antifibrotic agent, and/or an antiinfective agent and/or a polymer; prevention of surgical adhesions |
| 08/25/2005 | US20050187109 Process for producing granules |
| 08/25/2005 | US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 08/25/2005 | US20050186294 Manual clitoral sensitizing mixture having a cooling agent chosen from oils of peppermint, cornmint, eucalyptus, camphor, citronella and cinnamon; vasodilation |
| 08/25/2005 | US20050186293 Drinkable tea for therapy of dermatitis including eczema characterized in that it contains extracts drawn from one, two or more medicinal herbs selected from Lightyellow Sophora Root, Isatis Leaf, and Terminalia Fruit |
| 08/25/2005 | US20050186288 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions |
| 08/25/2005 | US20050186285 Multiparticulate compositions with improved stability |
| 08/25/2005 | US20050186284 Pharmaceutically active ingredient and a starch, wherein pharmaceutically active ingredient is packaged by starch to form a microparticle; pleasant taste and acceptable disintegration speed in oral cavity; possesses sufficient mechanical strength so as to protect preparation during compression molding |
| 08/25/2005 | US20050186281 Dissolved phenolic antimicrobial agent is chloroxylenol, 2,4,*-trichloro-2*-hydroxydiphenyl ether, benzylalkonium chloride, or 4-chloro-3,5-dimethylphenol; glycol, glycerin, neutralizing agent, preservative, acrylic polymer, polysaccharide polymer, and/or deionized water; surfactant- and alcohol-free |
| 08/25/2005 | US20050186280 Carbopol" carboxy vinyl polymer stabilizer; topical formulations for eyes or skin; cream, ointment, gel, patches; drugs, cosmetics |
| 08/25/2005 | US20050186279 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 08/25/2005 | US20050186278 Gastroprotected formulations containing alph-amylase inhibitors |
| 08/25/2005 | US20050186277 Novel formulations for the administration of fluoxetine |
| 08/25/2005 | US20050186276 Pharmaceutical formulations |
| 08/25/2005 | US20050186275 Hydrophobic polymer of sodium carboxymethylcellulose, cellulose acetate, ethyl cellulose, hydroxypropylmethyl cellulose acetate succinate and cellulose acetate phthalate; microsphere forming glyceryl triacetate, -monostearate, or -behenate; paraffin wax or carnauba wax; and diluent; time-release agents |
| 08/25/2005 | US20050186274 Multilayer tablet |
| 08/25/2005 | US20050186273 Controlled release dosage form including a banded engine |
| 08/25/2005 | US20050186272 Pharmaceutical composition for oral application and method for preparing thereof |
| 08/25/2005 | US20050186271 Process for dispersing a fluid in a mass of solid particles |
| 08/25/2005 | US20050186270 Reduced lactose excipient content; replaced with cellulose; disintegrants of starch, sodium starch glycolate, croscarmellose sodium or calcium and/or crosslinked polyvinypyrrolidone(crospovidone); free of magnesium stearate, citric acid, ascorbic acid, and butylated hydroxyanisole |
| 08/25/2005 | US20050186269 Stabilized feverfew formulations |
| 08/25/2005 | US20050186268 Hard capsule |
| 08/25/2005 | US20050186267 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin |
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/25/2005 | US20050186264 Targeting drug/gene carriers to irradiated tissue |
| 08/25/2005 | US20050186263 PH-sensitive polymeric micelles for drug delivery |
| 08/25/2005 | US20050186262 Adhesive matrix reservoir affixed to side of backing layer and is comprised of felodipine or isradipine and fatty acid permeation enhancer; solvent-free; hypotensive agents; photosensitive drugs |
| 08/25/2005 | US20050186259 Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom |
| 08/25/2005 | US20050186258 Elastomeric gloves protectively coated with mixture of water soluble chlorhexidine gluconate (CHG); and benzalkonium chloride and/or cetyl pyridinium chloride; reduced humidity; free of powder or starch; reducing nosocomial infections by Grampositive bacteria, Gramnegative bacteria, fungi, and/or viruses |
| 08/25/2005 | US20050186257 Forming a mixture comprising a water insoluble active ingredient such as caffeine and film-forming ingredients, coating onto a substrate; drying; topical or oral administering by applying to a moist area of individual to release active ingredient; flavor or drug delivery |
| 08/25/2005 | US20050186256 Dissolvable film comprising an active ingredient and method of manufacture |
| 08/25/2005 | US20050186255 Feminine wipe for symptomatic treatment of vaginitis |
| 08/25/2005 | US20050186254 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 08/25/2005 | US20050186253 Fluid dose on ingestion sheet; accuracte dosage |
| 08/25/2005 | US20050186252 Chewable; organoleptic; partially hydrolyzed guar gum; no need for ingestion aid; compression molding |
| 08/25/2005 | US20050186246 To inhibit scarring when the implant is placed within an animal; e.g. nasal reconstruction or cosmetic implant; antiscarring agent e.g. a taxane |
| 08/25/2005 | US20050186245 Implantable sensors and implantable pumps and anti-scarring agents |
| 08/25/2005 | US20050186244 Polymer compositions and methods for their use |
| 08/25/2005 | US20050186239 Implantable sensors and implantable pumps and anti-scarring agents |
| 08/25/2005 | US20050186230 Injectable oil-in-water emulsion; less vein irritation; antineoplastic agents |
| 08/25/2005 | US20050186229 Pleasant-tasting aqueous liquid composition of prednisolone sodium phosphate |
| 08/25/2005 | US20050186225 Adenovirus formulations |
| 08/25/2005 | US20050186211 Use of mda-5 as an antiviral and antiproliferative agent |
| 08/25/2005 | US20050186177 Liquid interferon-beta formulations |
| 08/25/2005 | US20050186176 Compounds and compositions for delivering active agents |
| 08/25/2005 | US20050186161 Comprises neticonazole and a basic substance; high permeability into nail and also has high efficacy |
| 08/25/2005 | US20050186147 Cosmetic and pharmaceutical foam with solid matter |
| 08/25/2005 | US20050186146 Interleukin-13 antagonist powders, spray-dried particles, and methods |
| 08/25/2005 | US20050186145 such as etanercept and said ester anticholinergic e.g. scopine 9-methyl-fluorene-9-carboxylate methobromide; treating inflammatory or obstructive respiratory system disorders such as asthma or chronic obstructive pulmonary disease (COPD); inhalants |
| 08/25/2005 | US20050186144 Treatment methods |
| 08/25/2005 | US20050186143 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| 08/25/2005 | US20050186142 Kit and composition of imidazole with enhanced bioavailability |
| 08/25/2005 | US20050186141 Transdermal aerosol compositions |
| 08/25/2005 | US20050186139 Heat pressing a mixture of an active ingredient with abuse potential, a high strength polymer, and a wax into a controlled release dosage form; cannot be dispersed or even dissolved in such a manner that it may safely be administered parenterally, in particular intravenously |
| 08/25/2005 | US20050184427 casting matrices comprising a mixture of polymers, solvents and active components selected from drugs, flavors, fragrances, enzymes, preservatives, sweetners, colorants, spices or vitamins, onto wells and drying by applying of heat to form a film dosage unit |
| 08/25/2005 | US20050183768 Photovoltaic thin-film cell produced from metallic blend using high-temperature printing |
| 08/25/2005 | US20050183767 Solution based solar cells on flexible substrates, from alloys of copper, indium, selenium, sulfur; printing or web coating technologies; low cost |
| 08/25/2005 | US20050183731 Polymer compositions and methods for their use |
| 08/25/2005 | US20050183720 Valve for aerosol container |
| 08/25/2005 | DE29924789U1 New, stable crystalline polymorph (form III) of the diuretic torasemide, by controlled acidification of alkaline solutions, has more rapid dissolution than form I |
| 08/25/2005 | DE19549645C5 Zuckerfreie Produkte und Verfahren zu deren Herstellung Sugar-free products and processes for their preparation |
| 08/25/2005 | DE10293600B4 Transdermal patch for treating nicotine addiction by blocking acetylcholine and noradrenaline release comprises clonidine or a combination of atropine and scopolamine |
| 08/25/2005 | DE102004005784A1 Stable depot system for prolonged release of protein or peptide drugs, e.g. insulin, comprising phosphatidyl choline, cholesterol and cationic lipids |
| 08/25/2005 | CA2819492A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2558623A1 Surface directed cellular attachment |
| 08/25/2005 | CA2556254A1 Aqueous solution preparation containing camptothecins |
| 08/25/2005 | CA2556220A1 Chronotherapeutic compositions and methods of their use |
| 08/25/2005 | CA2555887A1 Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir |
| 08/25/2005 | CA2555882A1 Controlled release formulations |
| 08/25/2005 | CA2555791A1 Highly concentrated liquid formulations of anti-egfr antibodies |
| 08/25/2005 | CA2555666A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2555366A1 Remedy for external use for skin and mucosal injuries caused by viral infection |
| 08/25/2005 | CA2555121A1 Cosmetic and pharmaceutical foam with solid matter |
| 08/25/2005 | CA2554973A1 Particles for inhalation rapid release properties |
| 08/25/2005 | CA2554559A1 Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
| 08/25/2005 | CA2554271A1 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| 08/25/2005 | CA2553681A1 Intravascular delivery system for therapeutic agents |
| 08/24/2005 | EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/24/2005 | EP1566179A2 Agent containing fat (oil) which contains onion extract, the production and use thereof |
| 08/24/2005 | EP1566176A1 Synergistic antibacterial formulation and a method of making the same |
| 08/24/2005 | EP1566174A2 Flash-melt oral dosage formulation |
| 08/24/2005 | EP1566173A1 Pharmaceutical composition for oral application and method for preparing thereof |
| 08/24/2005 | EP1566167A1 Base for oral composition and oral composition |
| 08/24/2005 | EP1566166A1 Base for oral composition and oral composition |
| 08/24/2005 | EP1565908A1 Read/write device for optical memory and method therefore |
| 08/24/2005 | EP1565229A2 Apparatus and methods for activating a delivery device |
| 08/24/2005 | EP1565211A2 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 08/24/2005 | EP1565191A1 Delivery composition and method |